1 completed. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Completed 1 |
Follow R333: new trials by email Literature Review of R333 trials Research Report on R333
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Efficacy of Topical R333 in Patients With Discoid Lupus Erythematosus (DLE) and Systemic Lupus Erythematosus (SLE) Lesions R932333, Placebo - Lupus Erythematosus, Discoid, Lupus Erythematosus, Systemic | Phase 2 | Completed | Rigel Pharmaceuticals | 54 | 2012-08-01 | 2016-07-14 |
Lupus Erythematosus, Discoid (1) · Lupus Erythematosus, Systemic (1)
Canada (1) · United States (1)